Journal article
Heterogeneity of B Cell Functions in Stroke-Related Risk, Prevention, Injury, and Repair
Neurotherapeutics, Vol.13(4), pp.729-747
10/2016
DOI: 10.1007/s13311-016-0460-4
PMCID: PMC5081124
PMID: 27492770
Abstract
It is well established that post-stroke inflammation contributes to neurovascular injury, blood-brain barrier disruption, and poor functional recovery in both animal and clinical studies. However, recent studies also suggest that several leukocyte subsets, activated during the post-stroke immune response, can exhibit both pro-injury and pro-recovery phenotypes. In accordance with these findings, B lymphocytes, or B cells, play a heterogeneous role in the adaptive immune response to stroke. This review highlights what is currently understood about the various roles of B cells, with an emphasis on stroke risk factors, as well as post-stroke injury and repair. This includes an overview of B cell functions, such as antibody production, cytokine secretion, and contribution to the immune response as antigen presenting cells. Next, evidence for B cell-mediated mechanisms in stroke-related risk factors, including hypertension, diabetes, and atherosclerosis, is outlined, followed by studies that focus on B cells during endogenous protection from stroke. Subsequently, animal studies that investigate the role of B cells in post-stroke injury and repair are summarized, and the final section describes current B cell-related clinical trials for stroke, as well as other central nervous system diseases. This review reveals the complex role of B cells in stroke, with a focus on areas for potential clinical intervention for a disease that affects millions of people globally each year.
Details
- Title: Subtitle
- Heterogeneity of B Cell Functions in Stroke-Related Risk, Prevention, Injury, and Repair
- Creators
- Uma Maheswari Selvaraj - Department of Neurology and Neurotherapeutics, UT Southwestern Medical Center, 6000 Harry Hines Blvd, MC8813, Dallas, TX, 75390, USAKatherine Poinsatte - Department of Neurology and Neurotherapeutics, UT Southwestern Medical Center, 6000 Harry Hines Blvd, MC8813, Dallas, TX, 75390, USAVanessa Torres - Department of Neurology and Neurotherapeutics, UT Southwestern Medical Center, 6000 Harry Hines Blvd, MC8813, Dallas, TX, 75390, USASterling B Ortega - Department of Neurology and Neurotherapeutics, UT Southwestern Medical Center, 6000 Harry Hines Blvd, MC8813, Dallas, TX, 75390, USAAnn M Stowe - Department of Neurology and Neurotherapeutics, UT Southwestern Medical Center, 6000 Harry Hines Blvd, MC8813, Dallas, TX, 75390, USA. Ann.Stowe@utsouthwestern.edu
- Resource Type
- Journal article
- Publication Details
- Neurotherapeutics, Vol.13(4), pp.729-747
- DOI
- 10.1007/s13311-016-0460-4
- PMID
- 27492770
- PMCID
- PMC5081124
- NLM abbreviation
- Neurotherapeutics
- ISSN
- 1933-7213
- eISSN
- 1878-7479
- Publisher
- United States
- Grant note
- R01 NS088555 / NINDS NIH HHS
- Language
- English
- Date published
- 10/2016
- Academic Unit
- Pathology
- Record Identifier
- 9984065488102771
Metrics
34 Record Views